- Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ
- Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC
- Eli Lilly Closes in on a $2 Billion M&A Deal. What It Means for the Stock. Barron’s
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies investor.lilly.com
- Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo
Leave a Reply